Search Results
125 items found for "design pharmaceuticals"
- Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update
"Geneva, Switzerland, August 18, 2022 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical
- Addex Therapeutics Completes Patient Enrollment For Dipraglurant Blepharospasm Phase 2 Clinical ...
Geneva, Switzerland, April 13, 2022 - Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical
- Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
Geneva, Switzerland, March 7, 2022 – Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical
- Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment ...
Geneva, Switzerland, April 6, 2022 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical
- VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron
Confo Therapeutics today announced that it has entered into a collaborative agreement with Regeneron Pharmaceuticals
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
Tagging GPCRs expressed in cellular compartments such as the nucleus or endosomes presents several pharmaceutical Therefore, it is essential to design tagging strategies that minimize interference with GPCR function Overall, the pharmaceutical challenges associated with tagging GPCRs expressed in cellular compartments Pharmaceuticals (Basel, Switzerland), 14(5), 439. https://doi.org/10.3390/ph14050439 Chen, K.
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
recently had the pleasure of speaking with Beth Fleck, Director of In Vitro Pharmacology at Crinetics Pharmaceuticals
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
"Geneva, Switzerland, August 15, 2022 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Team Leader Antibody Discovery Staff Scientist (AC-TAP) in Database Development at Department of Drug Design Apprentice Head of Human Resource Business Partners Senior Scientist, In vitro pharmacology - Crinetics Pharmaceuticals Senior Director, In vitro pharmacology - Crinetics Pharmaceuticals Explore Dr.
- Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...
given the Society’s conference will be held in Perth next year, in collaboration with the Australasian Pharmaceutical
- To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...
inactive conformation using molecular dynamic simulations "The δ-opioid receptor (DOR) is a critical pharmaceutical
- 📰 GPCR Weekly News, August 28 to September 3, 2023
Multi-Product Pipeline Toward Clinical Studies Confo Therapeutics Appoints Dieter Weinand, Former CEO Of Bayer Pharmaceuticals Wainwright 25th Annual Global Investment Conference X4 Pharmaceuticals to Participate in the Morgan Stanley
- Addex raises $4.2 million in equity financing
Switzerland, July 22, 2022 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical
- 📰 GPCR Weekly News, March 25 to March 31, 2024
Advances in GPCRs: Structure, Mechanisms, Disease, and Pharmacology Industry News Monash University pharmaceutical Data on DT-9045, a First-in-class Negative Allosteric Modulator of PAR2 for Immuno-oncology Crinetics Pharmaceuticals Drug Discovery & Development In Endocrine And Metabolic Diseases How biotech companies are using AI to design
- 📰 GPCR Weekly News, February 6 to 12, 2023
Phase 2 Study Part 1 IPO Raises $161M for GPCR-Based Drug Developer Structure Therapeutics Crinetics Pharmaceuticals PhD student at the Department of Drug Design and Pharmacology Computational drug design postdoc at the Department of Drug Design and Pharmacology Software / database development PhD student at Department of Drug Design and Pharmacology Software / database development postdoc at the Department of Drug Design and Pharmacology Postdoc in Bioinformatics/Data Science at Department of Drug Design and Pharmacology
- 📰 GPCR Weekly News, July 10 to 16, 2023
Poon to Board of Directors Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing - Natural Sciences - Surgery NEW Senior Scientist- Membrane Technologies NEW Computational Protein Design
- 📰 GPCR Weekly News, May 15 to 21, 2023
Methods & Updates in GPCR Research Computational design of dynamic receptor-peptide signaling complexes Industry News X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market Andrew
- Addex Raises $10 Million In Equity Financing
Switzerland, December 17, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical
- 📰 GPCR Weekly News, February 20 to 26, 2023
Industry News Josephine (Pina) Cardarelli from GPCR Therapeutics on Beyond Biotech Podcast Crinetics Pharmaceuticals PhD student at the Department of Drug Design and Pharmacology Computational drug design postdoc at the Department of Drug Design and Pharmacology Software / database development PhD student at Department of Drug Design and Pharmacology Software / database development postdoc at the Department of Drug Design and Pharmacology Postdoc in Bioinformatics/Data Science at Department of Drug Design and Pharmacology
- 📰 GPCR Weekly News, May 6 to 12, 2024
Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults Crinetics Pharmaceuticals Update Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024 Crinetics Pharmaceuticals
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating Specialist - Natural Sciences - Surgery Senior Scientist- Membrane Technologies Computational Protein Design
- 📰 GPCR Weekly News, November 6 to November 12, 2023
Reports Financing Highlights Neurocrine Biosciences Provides Development Pipeline Update Crinetics Pharmaceuticals Team Leader Antibody Discovery Staff Scientist (AC-TAP) in Database Development at Department of Drug Design
- 📰 GPCR Weekly News, September 18 to 24, 2023
Submit your logo design by November 1st. You don't need to be registered to participate. Research Associate Research Technician Senior Research Associate, In Vitro Pharmacology - Crinetics Pharmaceuticals
- 📰 GPCR Weekly News - January 2 to 8, 2023
Voyager’s GBA1 Program and Other Next-Generation Gene Therapies for Neurological Diseases Crinetics Pharmaceuticals
- Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes
in nearly all physiological systems make GPCR the largest protein family targeted for development of pharmaceuticals
- 📰 GPCR Weekly News, August 7 to 13, 2023
develop new therapies for people living with obesity, diabetes and other serious metabolic diseases X4 Pharmaceuticals
- 📰 GPCR Weekly News, February 12 to 18, 2024
polarization during bacterial infection Industry News InterAx Biotech's AI platform unlocks new drug designs for diabetes, obesity, and cancer Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2023
- 📰 GPCR Weekly News, January 16 to 22, 2023
amended deal with Gilead on anti-CCR8 antibody InterAx Biotech Announces the Appointment of Seasoned Pharmaceutical